Result of AGM

RNS Number : 5813B

Circassia Pharmaceuticals Plc

07 June 2019

 

7 June 2019

Circassia Pharmaceuticals plc

Result of Annual General Meeting 2019 and Re Directorate

Circassia Pharmaceuticals plc ("Circassia") announces that at its Annual General Meeting held today all resolutions set out in the notice of Annual General Meeting dated 1 May 2019 were passed.  A poll was conducted on each resolution proposed at the Meeting and the number of votes cast for and against each of the resolutions, and the number of votes withheld, were as follows:

	Resolution	For	%	Against	%	Withheld*
1	To receive the Annual report and accounts	322,919,875	100.00	13	0.00	7,000
2	To approve the Directors' Annual report on remuneration	322,890,903	99.99	33,885	0.01	2,100
3	To approve the Directors' Remuneration policy	321,934,551	99.69	990,237	0.31	2,100
4	To approve amendments to the rules of the Circassia Pharmaceuticals plc Performance Share Plan	321,937,169	99.99	29,184	0.01	960,535
5	To re-elect Francesco Granata	322,893,492	99.99	26,296	0.01	7,100
6	To re-elect Steven Harris	322,893,492	99.99	26,296	0.01	7,100
7	To re-elect Julien Cotta	321,944,717	99.99	23,636	0.01	958,535
8	To re-elect Rod Hafner	322,893,459	99.99	26,329	0.01	7,100
9	To re-elect Jo le Couilliard	322,896,152	99.99	23,636	0.01	7,100
10	To re-elect Sharon Curran	322,896,152	99.99	18,636	0.01	12,100
11	To re-appoint PricewaterhouseCoopers LLP as Auditors	321,962,457	99.70	956,141	0.30	8,290
12	To give authority to determine the Auditors' remuneration	322,896,152	99.99	16,636	0.01	14,100
13	To give authority to allot shares	322,890,902	99.99	23,886	0.01	12,100
14	To give authority to disapply pre-emption rights**	322,889,262	99.99	22,288	0.01	15,788
15	To give authority to disapply pre-emption rights in respect of an additional 5% of the Company's issued share capital**	321,939,017	99.70	973,723	0.30	14,598

* A vote withheld is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

** Special resolution.

As previously announced Russ Cummings did not seek re-election at the Annual General Meeting and accordingly has today stepped down as a Director.

For enquiries, contact:

Julien Cotta, Company Secretary	Tel: [phone]
Peel Hunt (Nominated Adviser and Joint Broker) James Steel / Dr Christopher Golden	Tel: [phone]
Numis Securities (Joint Broker) James Black / Freddie Barnfield	Tel: [phone]
FTI Consulting Simon Conway / Ciara Martin	Tel: [phone]

 

END

 

 

RAGLLFLERDIDIIA